X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18) 18
aged (17) 17
female (17) 17
male (17) 17
lung neoplasms - drug therapy (14) 14
oncology (14) 14
middle aged (13) 13
adult (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
carcinoma, small cell - drug therapy (9) 9
chemotherapy (9) 9
cisplatin - administration & dosage (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
cisplatin (7) 7
combined modality therapy (7) 7
drug administration schedule (7) 7
treatment outcome (7) 7
animals (6) 6
etoposide (6) 6
follow-up studies (6) 6
lung neoplasms - radiotherapy (6) 6
carcinoma (5) 5
carcinoma, non-small-cell lung - drug therapy (5) 5
carcinoma, small cell - radiotherapy (5) 5
lung neoplasms - mortality (5) 5
cell line (4) 4
cisplatin - adverse effects (4) 4
docetaxel (4) 4
etoposide - administration & dosage (4) 4
lung neoplasms - pathology (4) 4
survival analysis (4) 4
survival rate (4) 4
taxoids - administration & dosage (4) 4
trial (4) 4
antigens, viral - analysis (3) 3
antineoplastic agents, phytogenic - administration & dosage (3) 3
carcinoma, non-small-cell lung - pathology (3) 3
carcinoma, small cell - mortality (3) 3
combination (3) 3
combination chemotherapy (3) 3
cyclophosphamide (3) 3
doxorubicin (3) 3
doxorubicin - administration & dosage (3) 3
gemcitabine (3) 3
microscopy, electron (3) 3
neoplasm staging (3) 3
non-small-cell lung cancer (3) 3
paclitaxel (3) 3
plus cisplatin (3) 3
small cell lung cancer (3) 3
survival (3) 3
taxoids - adverse effects (3) 3
vinorelbine (3) 3
aged, 80 and over (2) 2
antineoplastic agents, phytogenic - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
area under curve (2) 2
cancer (2) 2
carboplatin (2) 2
cells, cultured (2) 2
chemotherapy, combination (2) 2
clinical trials as topic (2) 2
cooperative-oncology-group (2) 2
cranial irradiation (2) 2
cricetinae (2) 2
cross-resistant chemotherapy (2) 2
cyclophosphamide - administration & dosage (2) 2
deoxycytidine - administration & dosage (2) 2
deoxycytidine - adverse effects (2) 2
deoxycytidine - analogs & derivatives (2) 2
drug resistance (2) 2
evaluation (2) 2
herpesvirus 4, human - immunology (2) 2
ifosfamide (2) 2
irinotecan (2) 2
karyotyping (2) 2
leukemia, hairy cell - pathology (2) 2
lung cancer, small cell (2) 2
mammary neoplasms, experimental - microbiology (2) 2
medicine, research & experimental (2) 2
metaanalysis (2) 2
mitomycin (2) 2
multicenter (2) 2
neoplasm recurrence, local (2) 2
neoplasm transplantation (2) 2
non-small cell lung cancer (2) 2
oncology-group (2) 2
pharmacology & pharmacy (2) 2
phase ii study (2) 2
prognosis (2) 2
prognostic factor (2) 2
prophylactic cranial irradiation (2) 2
quality-of-life (2) 2
radiation-therapy (2) 2
receptors, antigen, b-cell - analysis (2) 2
research (2) 2
respiratory system (2) 2
retroviridae - isolation & purification (2) 2
small-cell lung cancer (2) 2
taxoids - pharmacokinetics (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lung Cancer, ISSN 0169-5002, 2003, Volume 41, Issue 1, pp. 13 - 20
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 6/2007, Volume 60, Issue 1, pp. 53 - 59
We conducted a phase I/II study of triplet chemotherapy consisting of cisplatin (CDDP), docetaxel (DCT) and gemcitabine (GEM) in patients with advanced... 
Biomedicine | Gemcitabine | Docetaxel | Non-small-cell lung cancer | Oncology | Cancer Research | Phase I/II study | Pharmacology/Toxicology | Cisplatin | SURVIVAL | PLUS CISPLATIN | GEFITINIB | VINORELBINE | IFOSFAMIDE | ETOPOSIDE | ONCOLOGY | docetaxel | III RANDOMIZED-TRIAL | PHARMACOLOGY & PHARMACY | gemcitabine | QUALITY-OF-LIFE | cisplatin | VINDESINE | phase I/II study | non-small-cell lung cancer | COOPERATIVE-ONCOLOGY-GROUP | Lung Neoplasms - drug therapy | Cisplatin - pharmacokinetics | Nausea - chemically induced | Area Under Curve | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Metabolic Clearance Rate | Cisplatin - administration & dosage | Dose-Response Relationship, Drug | Deoxycytidine - pharmacokinetics | Leukopenia - chemically induced | Adult | Deoxycytidine - adverse effects | Female | Taxoids - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Deoxycytidine - administration & dosage | Neoplasm Recurrence, Local | Treatment Outcome | Taxoids - pharmacokinetics | Pregnancy | Taxoids - administration & dosage | Vomiting - chemically induced | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Cisplatin - adverse effects | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Antimitotic agents | Chemotherapy | Care and treatment | Cancer patients | Oncology, Experimental | Analysis | Respiratory tract diseases | Research | Lung cancer, Non-small cell | Antineoplastic agents | Cancer
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Journal of Bronchology, ISSN 1070-8030, 10/2003, Volume 10, Issue 4, pp. 264 - 267
Journal Article
Cancer, ISSN 0008-543X, 1993, Volume 72, Issue 5, pp. 1597 - 1601
Background. Small cell lung cancer (SCLC) is highly sensitive to chemotherapy. Despite the introduction of intensive combination chemotherapy, long-term... 
hybrid regimen | drug resistance | small cell lung cancer | chemotherapy | TRIAL | MULTICENTER | THERAPY | ONCOLOGY | HYBRID REGIMEN | SMALL CELL LUNG CANCER | DRUG RESISTANCE | COMBINATION CHEMOTHERAPY | CROSS-RESISTANT CHEMOTHERAPY | CARCINOMA | REGIMENS | CHEMOTHERAPY | Carcinoma, Small Cell - secondary | Lung Neoplasms - drug therapy | Cyclophosphamide - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - radiotherapy | Lung Neoplasms - pathology | Male | Cyclophosphamide - adverse effects | Cisplatin - administration & dosage | Vincristine - administration & dosage | Adult | Female | Doxorubicin - administration & dosage | Etoposide - adverse effects | Carcinoma, Small Cell - drug therapy | Carcinoma, Small Cell - radiotherapy | Neoplasm Recurrence, Local | Etoposide - administration & dosage | Survival Rate | Combined Modality Therapy | Cranial Irradiation | Remission Induction | Pilot Projects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Vincristine - adverse effects | Aged | Carcinoma, Small Cell - pathology | Doxorubicin - adverse effects | Evaluation | Chemotherapy, Combination | Cyclophosphamide | Physiological aspects | Etoposide | Lung cancer, Small cell | Research | Drug resistance | Doxorubicin | Vincristine | Cisplatin
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.